Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR
This study has been completed.
First Posted: January 31, 2011
Last Update Posted: April 26, 2013
Information provided by (Responsible Party):